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1 Introduction
People have had a passion for weapons of mass destruction 
since the government military agencies search for chemical 
weapons culminating with the use of poisonous gases in the First 
War. During the Cold War, there were many rumors of research 
on biochemical and biological weapons since intelligence 
agencies of North America and Russian, used different types 
of weapons, such as radioactive, poison and contagious disease 
weapons, agaist their political enemies because these weapons 
cause diseases that could be above suspicion. It is important to 
emphasize that Prions also have this characteristic. Therefore 
it is plausible that Prion weapons can be used not only by 
governments but also by terrorists.
Furthermore, hypothetically, if Prions were used as a 
biochemical weapon, they could damage not only humans and 
animals, but the worldwide economies; therefore, even if Prions 
do not kill instantly a target, they can be a very persuasive object 
for those who have access to it.Prion diseases include a group 
of fatal neurodegenerative and infectious disorders in humans 
such as Creutzfeldt-Jacob disease (CJD), a variant form of CJD 
(vCJD), Gerstmann-Sträussler-Scheinker syndrome (GSS), and 
kuru, fatal familial insomnia (FFI); in animals, they include: 
scrapie of sheep and goats, chronic wasting disease (CWD) 
of mule deer and elk, and bovine spongiform encephalopathy 
(BSE) of cattle (Prusiner, 1996). The central feature of these 
disorders is the conformational change of the host encoded, 
cellular Prion protein (PrPc), see figures  (Figure  1A and 
Figure 2B, C) to an abnormal, partially proteinase K resistant 
and infectious isoform (PrPSc) with an aggregation propensity 
accumulating in the brain of diseased individuals (Figure 1B 
and Figure 2D) (Gambetti et al., 2003; Tatzelt & Schätzl, 2007). 
Cases of vCJD in Great Britain and France raised the possibility 
that BSE has been transmitted to humans (Bateman et al., 1995; 
Cousens et al., 1997). Macaque monkeys and marmosets both 
developed neurologic disease several years after inoculation 
with bovine Prions (Baker et al., 1993; Ono et al., 2011). These 
experiments clearly show that the inoculation of Prions is 
potentially fatal, and the fact that Prion strains are transmitted 
between species raised the possibility that a large section of 
the population is at high risk as a result of exposure to BSE 
Prions (Anderson et al., 1996; Sweeting et al., 2010; Bruce et al., 
1997; Collinge et al., 1996; Griffin, 1997; Lasmézas et al., 1996; 
Scott et al., 1993).
Prions have key features which help them to survive in the 
environment for long periods, such as the resistance to protein 
degradation, “partially resistant to proteinase K” (Bolton et al., 
1982; Prusiner, 1991), high resistant when exposed to 
irradiation, heat, and harsh chemical treatments (Plum, 1997), 
plus the fact that they can be attached to soil (Johnson et al., 
2006; Saunders  et  al., 2011a) and spread through air, and 
therefore they are extremely hazardous (Denkers et al., 2010). 
Although Prions are just only a polypeptide sequence, they are 
resistant to heat since people who consumed contaminated 
meat after preparation got sick; this raised the possibility that 
a particular conformation of bovine PrPSc was selected for 
heat resistance during the manufacture of meat and bone meal 
(MBM). Therefore, it is believed that MBM is the source of 
Prions responsible for BSE (Prusiner, 1997).
Therefore, hypothetically, Prions can be manufactured 
based on the molecular characteristics of the Prion protein 
to make deadly biochemical weapons. The study on how the 
conversion of PrPC (the normal cellular protein) into PrPSc 
(the abnormal disease-causing isoform) (Supattapone, 2010) 
can generate polypeptide sequences designed exclusively to kill.
Basically, an ideal Prion polypeptide sequence to be used as a 
biochemical weapon must be easily recombined and produced 
in large scale (Supattapone, 2010), be resistant to cold and heat, 
be fatal in very small quantities, and be transmitted through 
air, as demonstrated by (Denkers et al., 2010; Haybaeck et al., 
2011), and through water, food and  soil, as demonstrated 
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is a possible mechanism for triggering the conversion of 
PrPc into PrPSc where α-helices appear to be converted into 
β-sheets (Zhang et al., 1995). However, no atomic-resolution 
structure of the fibrillar state, which is likely to be infectious, 
has been reported to date because characterizing the structure 
of PrPSc has been challenging due to the difficulty in studying 
it through Nuclear magnetic resonance (NMR) or X-ray 
crystallography methods (Wasmer et al., 2008). However, there 
is  a structural model based on solid-state nuclear magnetic 
resonance restraints for amyloid fibrils from the Prion-forming 
domain (residues 218 to 289) of the HET-s (het-s/S locus) 
that occur naturally in the filamentous fungus Podospora 
anserine (Figure 2D) (Wasmer et al., 2008; Dalstra et al., 2005). 
Nevertheless, the basis of PrPSc conversion has been elucidated. 
Some models with the earliest conversion events involving 
PrPSc have been established suggesting that the formation of 
the disease-causing isoform involves refolding in two of the PrPc 
NH2-terminal (N-terminal) α-helix (H1 and H2) into β-sheets 
or the two β-strands (S1 and S2) and proposing to “seed” β-sheet 
elongation as the short α-helix H1 (Figure  1) (Huang  et  al., 
1996; Muramoto et al., 1996); the single disulfide bond joining 
COOH-terminal helices (C-terminal) would remain intact 
because the disulfide is required for PrPSc formation (Figure 1) 
(Pan et al., 1993; Muramoto et al., 1996).
by (Saunders  et  al., 2009; Saunders  et  al., 2011a), Gough & 
Maddison (2010) and (Smith et al., 2011). If Prions do not meet 
all specifications necessary of a biochemical weapon to kill, 
they at least have key features such as surviving through the 
digestive system, as demonstrated by Sales (2006), resistance to 
high temperatures during food preparation processes (Prusiner, 
1997), recombinant Prions are infectious, as demonstrated by 
(Wang et al., 2010; Legname et al., 2004; Makarava et al., 2010), 
and lastly, a few molecules can produce a chain reaction in the 
conversion of PrPc into PrPSc causing a fatal neurodegenerative 
disease (Rigter et al. 2009).
2 Prion molecular factors involved in the conversion 
of the native form PrPc into the infective form PrPSc, 
which could be explored for evil plans
The basic mechanisms involved in  the conversion 
PrPc  into  PrPSc are mainly achieved in four routes: the 
first includes the conformational mechanisms; the second 
includes the structural mechanisms; the third is related to the 
environmental pH; and fourth is the pathologic route.
The first route is associated to the lethality of the peptides, 
which involves a conformational change, through which the 
alfa (α)-helical content diminishes and the amount of beta 
(β)-sheet increases (Pan  et  al., 1993). PrPSc formation is a 
posttranslational process involving only a conformational 
change in PrPC. A comparison of the secondary structures 
shows that PrPc is 42% α-helical with a very low (3%) β-sheet 
content, whereas  PrPSc consists of 30%  α-helices and 
43%  β-sheets (Figure  1). Although the precise physiological 
role of PrPSc and the chemical differences between PrPSc and 
normal Prion protein (PrP) remain unknown, it appears that 
the differences are conformational (Prusiner, 1998). The Prions 
conformational transition from PrPc to PrPSc is accompanied 
by profound changes in the properties of the protein: PrPc is 
soluble in nondenaturing detergents, whereas PrPSc is not 
(Meyer et al., 1986) and PrPC is readily digested by proteases, 
whereas PrPSc is partially resistant (Kocisko  et  al., 1994; 
Hsiao et al., 1989) (Figure 1B). However, it is not fully known 
how disease-causing Prions arise in patients with sporadic 
forms; the main hypothesis is the horizontal transmission of 
Prions from humans or animals (Haley et al., 2011). Therefore it 
seems that the diseases caused by Prions are diseases of dietary 
origin, raising a great possibility that the PrPSc conformation 
is highly resistant to the mechanisms of animal polypeptides 
digestion, which is a key feature for a biochemical weapon (Sales, 
2006). The second route is the structural mechanisms, which 
are associated with the basic structural transition from PrPc 
to PrPSc. Peptide fragments corresponding to Syrian hamster 
PrP residues 90 to 145 and 109 to 141, which contain the most 
conserved residues of the Prion protein and the first two putative 
α-helical regions, were studied using infrared spectroscopy 
and circular dichroism. The peptides could be induced to form 
α-helical structures in aqueous solutions and in the presence 
of organic solvents such as trifluoroethano or detergents such 
as sodium dodecyl. On the other hand, NaCl at physiological 
concentration or acetonitrile induced the peptides to acquire 
substantial β-sheet. The results suggest that perturbation of 
the packing environment of the highly conserved residues 
Figure  1. (A) Normal Human Prion protein (HuPrP) with 43% of 
α-helix, sensitive to proteinase K treatment without forming aggregates. 
The NH2-terminal (letter N in Figure) region (residues 23–124) is 
flexible, and the COOH-terminal (letter C in Figure) region (residues 
125–228) that contains the globular domains is well structured the 
structures contain intramolecular disulfide bridge (S-S yellow trace 
in Figure), three α-helices, (H1), (H2), and (H3), red color, and a 
short double-stranded β-sheet (S1) and (S2). (H) and (S) indicate 
α-helix and β-strand, respectively (indicated by the blue arrows), and 
a disulfide bridge S-S  (trace). (B) Human Prion protein infectious 
isoform (HuPrPSc) with 30% of α-helix and 43% of β-sheet, resistant 
to proteinase K treatment and capable of forming aggregates. The two 
β-strands (S1) and (S2) are proposed to “seed” β-sheet elongation (gray 
and blue colors) as the short α-helix (H1) unfolds and is converted 
into the PrPSc conformation. (H2) and (H3) remain stabilized via 
linkage of a disulfide bridge (yellow trace). (B) α-helix (red color), 
β-sheet elongation (gray and blue colors), and disulfide bridge S-S 
(yellow trace). Courtesy of Cayman Chemical Company. Ann Arbor, 
Michigan. USA.
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pH 4.1 can convert into the β-sheet conformation at pH 3.6 
but not vice versa a loss of α-helix since the gain of β-sheets 
and a number of PrPSc-like conformations can be generated 
by incubating recombinant PrPc  at low pH, indicating that 
the protonation of key residues is likely to destabilize PrPc 
facilitating its conversion to PrPSc. Fold stability of human PrPc 
as a function of pH is significantly reduced by the protonation 
of two histidine residues, His187 and His155. Mutation of 
His187 to an arginine imposes a permanently positively charged 
residue in this region of the protein and has a dramatic effect 
on the folding of PrPc resulting in a molecule that displays a 
markedly increased propensity to oligomerize. The oligomeric 
form is characterized by an increased β-sheet content, loss of 
fixed side chain interactions, and partial proteinase resistance. 
Therefore, the protonation state of H187 appears to be crucial 
in determining the conformation of PrP; the unprotonated 
form favors native PrPc, while the protonated form favors 
PrPSc-like conformations (Hosszu et al., 2010; Gerber et al., 
2008; Hosszu et al., 2009). If these conditions are relevant, as 
there is considerable evidence that endosome-like organelles or 
Theoretically, the high β-sheet content of PrPSc was 
predicted based on its ability to polymerize into amyloid fibrils 
(Prusiner et al., 1983; Caughey et al., 1991). Studies have found 
that the deletion of each of the four predicted helices prevented 
PrPSc formation, as did the deletion of the stop transfer effector 
region and the C178A mutation. The removal of a 36-residue 
loop between helices 2 and 3 did not prevent formation of 
protease-resistant PrP; the resulting  scrapie-like  protein, 
designated PrPSc106, contained  106 residues after cleavage 
of an N-terminal signal peptide and a C-terminal sequence 
for glycolipid anchor addition.The addition of the detergent 
Sarkosyl to cell lysates solubilized PrPSc106, which retained 
resistance to digestion by proteinase K. These results suggest 
that the regions of a proposed secondary structure in PrP 
and the disulfide bond stabilizing helices 2 and 3 are required 
for PrPSc formation (Rogers et al., 1993; Fischer et al., 1996; 
Muramoto et al., 1996). The third route is related to the pH 
environment. The pH seems to be important for  the change 
of  conformation because human PrPc has a pH-dependent 
conformational change. The α-helical intermediate formed at 
Figure 2. (A) Illustration of the normal structure of human Prion protein gene (PRNP). PrPc is synthesized from a 254 amino acid precursor. 
The nascent peptide is cleaved at both the N-and C-terminal in the Endoplasmic Reticulum (ER). A glycosylphosphatidylinositol anchor (GPI) 
(purple) is attached to the C-terminus at position 231 of PrPc that helps link it to the extracellular membrane (lipid bilayer).In the Golgi, PrPc is 
N-glycoslyated at positions 181 and 197. Mature PrPc consists of the amino acid residues 23-231 and is expressed as a membrane glycoprotein 
anchored to the cell surface by a GPI moiety. (H) and (S) indicate α-helix and β-strandregions, respectively. (S-S) and (Y) “inverted” indicate a 
disulfide bond and N-glycosylation sites, respectively. (OR) specific octapeptide repeat. (B) Mature PrPc dimer. Under native conditions, part of 
the native bovine PrPc exists as a monomer-dimer equilibrium. It is theorized from this dimeric structure that the dimerization is the first step 
in amyloid formation and the presence of these dimers could possibly speed up the aggregation of PrPSc. (C) The mature human PrPc protein.
(B and C) NH2-terminal (letter N in Figure), COOH-terminal (letter C in Figure), α-helix (H1-H3) and β-strand (S1 and S2 in Figure). (D) A 
model for fibrils of fungal HET-s Prion forming domain. Since no structural data for PrPSc have been reported to date, this is shown for comparison. 
The organization of this fibril is a left-handed β-solenoid with dense, parallel β-sheet packing. The β-solenoid fold has been proposed for PrPSc. 
(A) Courtesy of Cayman Chemical Company. Ann Arbor, Michigan. USA. (B-C) Adapted From: Sekijima, M. Molecular dynamics simulation 
of dimeric and monomeric forms of human Prion protein: insight into dynamics and properties. Biophys J. With permission. (D) Adapted From: 
Wasmer, C. Amyloid fibrils of the HET-s(218-289) Prion form a beta solenoid with a triangular hydrophobic core. Science. With permission.
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for all of the transport of Prions, and other cells, including 
tingible-body macrophages (phagocytic cells in lymphoid 
germinal centers) are plausible locations for PrPSc propagation 
(Arnold et al., 1995; Aguzzi & Sigurdson, 2004) since PrP is 
captured by phagocytes of the immune system.Therefore, the 
conformational convertion of PrPc into PrPSc can be triggered 
by endocytosis of a Prion particle, and a phagocytic cell may 
trigger the disease with a particle reaching the brain by the 
sympathetic nervous system from the lymphatic tissues (Harris 
& True, 2006; Aguzzi et al., 2008; Aguzzi et al., 2001; Venneti, 
2010). Therefore, the immune system is a target of lethal 
Prions, which could be added to adjuvants that are intended to 
perform phagocytosis by DCs to increase their efficiency and 
thus be transmitted through small wounds or scratches on the 
victim’s skin.
3 Discussion
Recombinant Prions with fatal features could be developed 
in relatively simple laboratories using animals such as rats, 
mice, and monkeys (Supattapone, 2010;  Wang  et  al., 2010; 
Legname et al., 2004; Makarava et al., 2010). Ricin has already 
been used as a weapon (Augerson, 2000; National Security Notes, 
2004), for example in the case that caught the full attention of 
international media and was described by Papaloucas et al 
(2008) and which was about a political dissident that was killed 
by a supposed KGB agent using a single ricin-tipped umbrella 
as a weapon. Consequently, the same mechanism can be used to 
deliver Prions using simple objects without giving the victim a 
chance to receive a vaccine, treatment, or a specific anti-serum 
injection. Some political enemies must be eliminated and Prions 
can be a possible alternative to the use of venoms, precisely 
because Prions do not kill instantly and make the investigation 
process very difficult to trace the assassin agent. Another class 
of venom that have been used before and can be substituted by 
Prions are the radioactive venom (Jordan & Finn, 2006) because 
Prions can cause the same effect. One advantage is leaving no 
traces detectable  by anti-gama radiation equipment, such as 
Geiger counter, and another advantage is being less dangerous 
to the assassin agent willing to use it.
The psychological effect caused by the use of Prions to 
extinguish rivals could be as powerful as the radioactive effects, 
and it can send a strong message such as “Do not play with the 
government interests”. The use of such weapons seems to have 
strong personal issues involved because it would be easier to 
kill someone simply using a gun, but with Prions, the victim 
agonizes for months before dying (Papaloucas et al., 2008). The 
most frightening possibility would be the use of Prions to get 
rid of enemies in large regions of ongoing conflicts or political 
separatist wars. In theory, it would not raise any suspicion by 
the international community because of its silence mechanisms, 
but after years a lot of people would start dying presenting the 
same symptoms and the alert would have come too late. If 
Prions are made in laboratories with the purpose to be spread 
in the air, it could kill a large number of people since it has 
been demonstrated that CWD can be dispersed as aerosol 
(Denkers et al., 2010;  Haybaeck et al., 2011; Ford et al., 2002). 
In addition, the decontamination of the environment can be a 
lysosomes, with their locally acidic environments are plausible 
locations for PrPSc propagation (Arnold  et  al., 1995), these 
models of Prions for these molecular regions are crucial for the 
development of disease via PrPSc, and theerefore the structure 
of these regions of the molecule can be exploited as a catalytic 
core for elaboration of new lethal Prions. Exploring mechanisms 
that allow the Prions to be captured by the airways as an aerosol 
microparticles; thus lesser amounts of Prions can be dispersed 
through the air and contaminate the water, soil, plantations, 
and very large regions. The fourth route is the pathologic 
route. Another mechanism of infection that could be very 
well explored is the pathogenesis. Prions could be related to 
microspheres directed to specific target cells and be embraced 
and activated by the endosomes pathway of many types of cells 
(Arnold et al., 1995). Pathogenesis can be divided into natural or 
congenital transmission and external transmission. The native or 
natural pathogenesis of Prion disease varies including mutation 
in human Prion protein gene (PRNP) and external transmitted 
causes (Tranulis et al., 2011). Figure 2A shows a normal structure 
of PRNP gene (Manson & Tuzi, 2001). Missense mutations and 
expansions in the octapeptide region (OR) result in familial 
forms of Creutzfeldt-Jakob disease (fCJD) and GSS (Beck et al., 
2010; Jansen et al., 2011; Kovács et al., 2002). On the other hand, 
FFI is caused by the D178N mutation, the disease progresses 
quickly, and the patient dies within a few months after the onset 
of symptoms sleep disorders with agitation, fractionated sleep, 
snoring, and daytime sleepiness  (Ayuso Blanco  et  al., 2006; 
Montagna  et  al., 2003). The inheritable  familial forms of all 
Prion diseases (fCJD, GSS, and FFI) are inherited as autosomal-
dominant disorders (Mastrianni, 2003). The polymorphism 
coding for methionine (M) or valine (V) at codon 129 of the 
Prion protein gene (PRNP M129V) plays a pivotal role in 
the susceptibility to CJD, influencing familial, transmitted, 
and sporadic forms of the disease (Alperovitch  et  al., 1999), 
homozygosity for methionine at position 129 (met/met at codon 
129) predisposes susceptibility and earlier age of onset of disease 
(Kretzschmar & Illig, 2009; Mead et al., 2009). Therefore, the 
PRNP polymorphisms is  related  to specific clinical forms of 
Prion diseases, and polymorphism in the regulatory region 
of PRNP is associated with increased risk of sporadic CJD 
(Sanchez-Juan et al., 2011).
The pathogenesis of external transmission. In theory, 
vCJD can be transmitted by ingestion of contaminated 
meat derived from cows with BSE.  PrPSc may be the major 
pathological mechanism to be explored because it survives 
the digestion process (Sales, 2006) and is hypothesized to 
be amplified by follicular dendritic cells and tingible body 
macrophages in gut-associated lymphatic tissue, such as Peyer 
patches. PrPSc  eventually reaches draining lymphatics and 
the spleen by migrating to follicular dendritic cells (Aguzzi & 
Sigurdson, 2004). Hypothetically, PrPSc reaches the brain via 
the sympathetic nervous system from lymphatic tissues, and 
PrPSc propagation in the brain causes accumulation resulting 
in neurodegeneration (Harris & True, 2006; Aguzzi  et  al., 
2008; Aguzzi et al., 2001; Venneti, 2010). Thus, theoretically, 
the conformation of Prions is pH dependent in endosome-like 
organelles or lysosomes with acidic environments. Dendritic 
cells (DCs) are obvious candidates, but DCs might not account 
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huge problem if Prions are not rapidly degraded in the soil by 
microorganisms; some studies have demonstrated that the soil 
is as possible reservoir of scrapie and CWD agents, which can 
persist in the environment for years. Attachment to soil particles 
likely influences the persistence and infectivity of Prions in the 
environment (Smith  et  al., 2011; Gough & Maddison, 2010; 
Saunders et al., 2009).
The evidence that soil and other environmental surfaces 
can play a role as reservoir of Prions dissemination contributes 
to the imminent threat these particles can represent if they 
are released into the environment (Maddison  et  al., 2010; 
Saunders et al., 2011b). Finally, the impact that Prions could 
cause to wildlife, especially mammals, is terrifying; people 
who had been in contact to contaminated environments or had 
ingested inoculated animals could die in days, months, or years.
The long effects of Prion contamination can be terrible 
and are similar to radioactive effects. Concluding, it is utmost 
important to alert the scientific community scientific community, 
agencies, and governments worldwide to discourage, inhibit, 
and investigate those who have this evil intention.
4 Final conclusions
Bioterrorism is as emerging threat that is growing with 
the development of biotechnology. The risk of biochemical 
weapons falling into wrong hands can be devastating; it could 
contaminate cattle, humans and many other animal species 
leading to thousands of deaths and would lead to a global 
pandemic and economic crisis too. 
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